Navigation Links
John Garibotto Joins Cellnovo's Board of Directors
Date:6/20/2013

SWANSEA, England, June 21, 2013 /PRNewswire/ --

Cellnovo, the leading innovator in mobile diabetes management technology, announced today the appointment of John Garibotto as non-executive director.

Mr. Garibotto is a 20 year veteran of the medical device industry and has been instrumental in the development, formation, and financing of highly successful medical device companies including Insulet Corporation (IPO May 2007, Nasdaq: PODD) and TransVascular, Inc. (acquired by Medtronic in Sept '04).  He is presently the founder and Chief Technology Officer of Securus Medical Group, Inc.  Mr. Garibotto has earned a B.Sc. in Industrial Technology from the University of Massachusetts at Lowell and a Masters in Business Administration from Northeastern University.

"It is a real pleasure to welcome John as director," said Eric Beard, Cellnovo's Executive Chairman.  "John has vast experience in complex medical device development.  His expertise and guidance will be invaluable as we prepare to submit our mobile-diabetes management system for US approval."

"I'm delighted to join the board of this outstanding company," said John Garibotto.  "Cellnovo has developed a game-changing approach to the treatment and follow up of patients with type 1 diabetes.  I am very impressed by the mobile, real-time technology that Cellnovo have used for their system, which will undoubtedly address the many unmet needs of both patient and care teams."

About Cellnovo

A UK-based medical device company, Cellnovo develops an innovative mobile diabetes management system. Comprised of a mobile connected patch pump, mobile touchscreen handset/controller, blood glucose meter and applications, the Cellnovo system provides intuitive operation, wireless Internet connectivity and real-time tracking, all industry firsts. For further information, please visit http://www.cellnovo.com.


'/>"/>
SOURCE Cellnovo
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations
2. John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations
3. Dr. Victor KR Matsudo Joins ActiGraph Scientific Advisory Board
4. StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500
5. Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
6. Dalia Dergham Joins Grace Century FZ LLC International Project Team
7. SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions
8. Elissa Guerra Joins Pursuit as VP of Client Solutions
9. Graphene joins the race to redefine the ampere
10. Provia Laboratories, LLC Joins Stoneham Chamber of Commerce in Massachusetts
11. Provonix Joins the Medrio Partner Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2019)... , ... November 08, 2019 ... ... artificial intelligence (AI)-powered technology for use in pathology research, today announced the ... biopsy samples from patients enrolled in the phase 3 selonsertib studies (STELLAR). ...
(Date:11/5/2019)... SOMERSET, N.J. (PRWEB) , ... ... ... leading global provider of advanced delivery technologies, development, and manufacturing solutions for ... of its next-generation cell line development technology, GPEx® Boost. The technology enhances ...
(Date:11/2/2019)... , ... October 31, 2019 , ... ... always used to communicating with each other: study managers, principal investigators, supply chain ... if a party is not informed of the latest data, potentially leading to ...
(Date:10/30/2019)... RAPID CITY, S.D. (PRWEB) , ... October 30, 2019 , ... ... a team of researchers and students at South Dakota School of Mines & ... kill cancer cells while leaving healthy cells alive. , If successful, the technique ...
Breaking Biology Technology:
(Date:11/12/2019)... Ore. (PRWEB) , ... November 12, 2019 , ... ... launching Cross-Channel Spend Optimizer that improves digital advertising performance up to 25% and ... Digital Advertising, Cross-Channel Spend Optimizer uses advanced multi-touch attribution (MTA) to predict best ...
(Date:11/9/2019)... ... November 08, 2019 , ... ... provider of specialized histology, pathology, biomarker development, and archiving services for the ... the mergers of Histo-Scientific Research Laboratories (HSRL), Vet Path Services (VPS) and ...
(Date:11/5/2019)... (PRWEB) , ... November 05, 2019 , ... ... and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today ... held at Hotel Sofia, Barcelona, Spain on Nov. 12 – 14, 2019. , ...
Breaking Biology News(10 mins):